TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

Trade (domestic/foreign) TRD

Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed above.

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Health Issues HCR

Healthcare reform draft legislative proposals, including the Affordable Health Choices Act (Senate draft) - provisions relating to pharmaceuticals.

Foreign entity interest: Teva Pharmecutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA Inc., has an indirect interest in the issues listed above.

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR)

Pharmacy PHA

S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA").

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA Inc., has an indirect in the issues listed above.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR)

Bills named: H.R. 1859 (111th), S. 767 (111th), S. 726 (111th), H.R. 1427 (111th), S. 301 (111th), H.R. 1548 (111th)

Copyright/Patent/Trademark CPT

H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.

Foreign entity interest: Teva Pharmaceutical Industires, Ltd., as an indirect parent of Teva Pharmaceuticals USA Inc., has an indirect interest in the issues listed above.

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 369 (111th), H.R. 1706 (111th), S. 610 (111th), S. 515 (111th), H.R. 1260 (111th)